相关实验视频
Updated: May 11, 2026
05:39
Shock Wave Application to Cell Cultures
Published on: April 8, 2014
12.8K
冲击波应用对老年人群中的各种慢性伤口有效吗? 预先临床研究预先临床研究
Robert Dymarek1, Izabela Kuberka2, Karolina Walewicz3
1Department of Physiotherapy, Wroclaw Medical University, Wroclaw, Poland.
Clinical interventions in aging
|May 6, 2024
概括
身体外冲击波疗法 (ESWT) 显著改善了老年人的慢性伤口. 一次辐射ESWT疗程减少了伤口大小,提高了临床分数,证明了它的有效性.
科学领域:
- 再生医学是一种再生医学.
- 皮肤病学 皮肤病学
- 老年病的医生 老年病的医生
背景情况:
- 身体外冲击波疗法 (ESWT) 已因其在治疗慢性伤口方面的有效性而得到认可.
- 对压力 (PU) 的ESWT的研究是有限的,大多数研究集中在糖尿病足 (DFU) 和静脉腿 (VLU) 上.
研究的目的:
- 调查辐射ESWT对老年人群慢性伤口的短期治疗效果.
- 评估ESWT对压力,静脉腿和糖尿病足的影响.
主要方法:
- 这项研究包括31名老年人的慢性伤口 (22个PU,7个VLU,2个DFU).
- 使用特定参数 (2.5 bar,0.15 mJ/mm2,5 Hz) 进行一次辐射ESWT.
- 伤口评估包括在基线和治疗后一周使用伤床评分 (WBS) 和贝茨-詹森伤口评估工具 (BWAT) 的数字平面测量和临床评估.
主要成果:
- 在ESWT后观察到伤口面积 (9.4厘米2到6.2厘米2),长度和宽度的统计学显著减少 (p<0.001).
- 临床评估显示显著改善:WBS增加了31.25%,BWAT增加了20.00% (p<0.001).
- 在WBS (r=-0.446,p=0.012) 和BWAT (r=0.327,p=0.073) 的平面测量和临床结果之间发现了显著的相关性.
结论:
- 辐射ESWT在老年人慢性伤口愈合方面显示出大量的即时临床益处.
- 即使是一次ESWT会话也可以成为治疗慢性伤口的有效和有益的干预措施.
相关概念视频
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...